UMC’s board members
UMC’s board consists of six members and their alternates, appointed by WHO and by the Swedish government.
The operations of UMC as a WHO Collaborating Centre are governed by an agreement between WHO Headquarters and the Swedish government. The centre has an international board – WHO and the Swedish government each appoint three members and alternate members.
Since May 2019, the board has been chaired by Dr Filippa Nyberg.
The members of the board are listed below.
Appointed by the Swedish government
- Dr. Filippa Nyberg (Chair)
Senior Consultant, Karolinska University Hospital, and Associate Professor, Karolinska Institutet - Dr. Karin Meyer
CEO, Center for Translational Research - Mr. Carl-Fredrik Högstedt
Head of Credit Investments, Skandia Investment Management
Alternates
- Dr. Björn Eriksson
Director General of the Swedish Medical Products Agency - Professor Gert Ragnarsson
Professor and Scientific Advisor - Mr. Gabriel Wikström
Former Minister for Public Health
Appointed by WHO
- Professor Rika Wakao, PhD
Project Professor at The University of Tokyo Graduate School of Medicine, Tokyo - Dr. Rogério Gaspar (Vice-Chair)
Director, Regulation and Prequalification, World Health Organization - Dr. Cejana Brasil Cirilo Passos
Agéncia Nacional de Vigilãncia Sanitára Ministerio de Saude
Alternates
- Dr. Nouf Saleh Al-Fadel
Drug Safety and Risk Management Department, Executive Directorate of Pharmacovigilance, Saudi Food and Drug Authority, Riyadh - Mr. Hiiti B. Sillo
Medicines Safety, Regulation and Prequalification, World Health Organization, Geneva - Dr. Rajeev Singh Raghuvanshi
Drugs Controller General of India at the Central Drugs Standards Control Organization, New Delhi